AMGEN INC (AMGN) Form 8-K Material Events
AMGEN INC (AMGN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AMGN
CIK: 318154
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerSurita Goehl
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3 | 2026-09-04 | 2026-09-01 | PRIMARY DOCUMENT | 0000318154-26-000139 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | PRIMARY DOCUMENT | 0000318154-26-000137 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001959173-26-005970 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-07 | PRIMARY DOCUMENT | 0000318154-26-000135 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001959173-26-005894 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | PRIMARY DOCUMENT | 0000318154-26-000133 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | PRIMARY DOCUMENT | 0000318154-26-000132 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | PRIMARY DOCUMENT | 0000318154-26-000131 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | PRIMARY DOCUMENT | 0000318154-26-000130 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | PRIMARY DOCUMENT | 0000318154-26-000129 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001958244-26-000492 | View SEC Doc Filr Page |
| 144/A | 2026-08-06 | — | 144/A Filing | 0001974078-26-000298 | View SEC Doc Filr Page |
| 144 | 2026-08-06 | — | 144 Filing | 0001974078-26-000295 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0000318154-26-000126 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0000318154-26-000124 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-29 | 8-K | 0000318154-26-000119 | View SEC Doc Filr Page |
| 11-K | 2026-06-11 | 2025-12-31 | 11-K | 0000318154-26-000114 | View SEC Doc Filr Page |
| 11-K | 2026-06-11 | 2025-12-31 | 11-K | 0000318154-26-000113 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | PRIMARY DOCUMENT | 0000318154-26-000108 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | PRIMARY DOCUMENT | 0000318154-26-000107 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | PRIMARY DOCUMENT | 0000318154-26-000106 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | PRIMARY DOCUMENT | 0000318154-26-000105 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | PRIMARY DOCUMENT | 0000318154-26-000104 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | PRIMARY DOCUMENT | 0000318154-26-000103 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-19 | PRIMARY DOCUMENT | 0000318154-26-000102 | View SEC Doc Filr Page |